KUBÍČEK, Luboš, Robert STAFFA, Zdeněk KŘÍŽ, Tomáš NOVOTNÝ and Robert VLACHOVSKÝ. Utilization of autologous superficial femoral vein graft in cases of infected prosthetic graft replacement and high infection-risk cases. In 33rd ESVS Annual Meeting 2019. 2019.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Utilization of autologous superficial femoral vein graft in cases of infected prosthetic graft replacement and high infection-risk cases
Authors KUBÍČEK, Luboš (203 Czech Republic, belonging to the institution), Robert STAFFA (203 Czech Republic, guarantor, belonging to the institution), Zdeněk KŘÍŽ (203 Czech Republic), Tomáš NOVOTNÝ (203 Czech Republic, belonging to the institution) and Robert VLACHOVSKÝ (203 Czech Republic, belonging to the institution).
Edition 33rd ESVS Annual Meeting 2019, 2019.
Other information
Original language English
Type of outcome Presentations at conferences
Field of Study 30212 Surgery
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/19:00108562
Organization unit Faculty of Medicine
Keywords in English autologous superficial femoral vein graft; acute mesenteric ischemia; biomarkers
Tags rivok
Changed by Changed by: MUDr. Tomáš Novotný, Ph.D., učo 23163. Changed: 10/1/2020 12:48.
Abstract
Introduction: Aortic prosthetic graft infection is one of the most severe complications in vascular surgery. Good results are reported for the replacement using autologous superficial femoral vein (SFV) graft. This extensive procedure might be complicated by acute mesenteric ischemia (AMI). The aim of the study was to evaluate the safety of the procedure and options of early postoperative mesenteric ischemia detection. Methods: A retrospective review of 64 cases in which we have used autologous SFV graft was performed. The serum levels of biomarkers of AMI were assessed in comparison to 40 elective aortic surgery cases. Results: Average follow-up was 46.6 +/- 33.0 months, 30-day mortality was 6.3 %. The specificity of currently studied biomarkers of AMI (procalcitonin, ischemia modified albumin, I-FAPB2, and D-lactate) was low. Conclusions: Our results support the use of SFV graft for the treatment of aortic graft infection. Early postoperative detection of AMI remains challenging.
Links
NV17-29701A, research and development projectName: Ischémií modifikovaný albumin a cirkulující mikroRNA jako nové technologie k monitorování tkáňové ischémie po cévních rekonstrukcích na břišní aortě
PrintDisplayed: 20/8/2024 19:51